ZURICH, SWITZERLAND--(Marketwire - August 12, 2008) - MD Biosciences, a global biotechnology company focused in inflammations & neurology research, will showcase its pre-clinical capabilities at the 12th World Congress on Pain (IASP) in Glasgow, Scotland, August 17th - 22nd, 2008. Capabilities included in the showcase are efficacy disease models within Nociceptive, Neuropathic, Post-operative and Inflammatory Pain.
